The systems enable precise, high-quality delivery of radiation therapy, with minimal negative side effects on patients during and after treatment, and a reduction in the number of treatments required. The systems take into account movement of the patient and the tumor in real time, to ensure on-target radiation delivery.

 

The CyberKnife and TomoTherapy Stereotactic Body Radiation Therapy (SBRT) systems are manufactured by Accuray (Sunnyvale, CA), and are the only robotic radiosurgery systems on the market that can deliver high-precision treatments throughout the body, for diseases of the prostate, brain, breast, liver, head, neck, lungs, spine, pancreas, kidney, and total marrow irradiation, amongst others.

 

The systems are specifically designed for Image-Guided Intensity-Modulated Radiation Therapy (IMRT) and are based on a Computed Tomography (CT) scanner platform. The systems can deliver radiation from any angle around the patients, continuously, or from specific beam angles. The systems use 3D image guidance to help enable clinicians to target only the tumor and avoid damaging normal, healthy tissue, resulting in fewer side effects for patients.

 

The CyberKnife M6 Series systems installed in Qatar and Latvia are intended for treatment of both oncological and non-oncological diseases, and for research purposes. In Bulgaria, Accuray installed the first TomoTherapy System in Sofia, in the Specialized Hospital for Active Treatment in Oncology (SBALO), for IMRT treatments.

 

Lionel Hadjadjeba, corporate senior VP, president worldwide commercial operations, Accuray, said, "The recent installations of Accuray technologies in Qatar, Latvia and Bulgaria indicate clinicians believe in the long-term benefits our devices can provide to their patients. We're committed to working with clinical teams around the world to ensure that with the CyberKnife and TomoTherapy Systems, they can significantly and positively impact the way cancer is managed."